TREATMENT OF LATE-ONSET SYNDROMES SECONDARY TO NEUROLEPTICS

ISBN-13: 9786203727098 / Angielski / Miękka / 52 str.

Hanen Ben Ammar; Jihed Mrizak; Ghada Hamdi

Opis

Remission rates for late onset syndromes, a serious and disabling side effect of dopamine receptor blocking agents, are low overall. An accurate phenomenological classification of these syndromes is needed to tailor treatment. The recommended treatment options have a low level of evidence. Clozapine has proven to be effective in clinical practice, particularly in cases of resistant schizophrenia and late onset syndrome. Other therapeutic alternatives seem promising.

O autorze

Ben Ammar, Hanen Dr. Hanen BEN AMMAR is a psychiatrist and teacher at the Faculty of Medicine of Tunis, University Tunis El Manar, graduated in Neuropsychopharmacology.